Journal
FRONTIERS IN GENETICS
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fgene.2021.658078
Keywords
HIV-1 protease; cleavage site prediction; positive-unlabeled learning; biased SVM; substrate specificity
Categories
Funding
- National Natural Science Foundation of China [61602352]
- Pioneer Hundred Talents Program of Chinese Academy of Sciences
Ask authors/readers for more resources
Understanding HIV-1 protease substrate specificity is crucial for HIV infection prevention. A novel positive-unlabeled learning algorithm, PU-HIV, has been proposed for effective prediction of HIV-1 protease cleavage sites, demonstrating superior performance compared to existing prediction models in terms of AUC, PR-AUC, and F-measure. With PU-HIV, previously unknown substrate sites can be identified, offering valuable insights for designing novel HIV-1 protease inhibitors for HIV treatment.
Understanding the substrate specificity of HIV-1 protease plays an essential role in the prevention of HIV infection. A variety of computational models have thus been developed to predict substrate sites that are cleaved by HIV-1 protease, but most of them normally follow a supervised learning scheme to build classifiers by considering experimentally verified cleavable sites as positive samples and unknown sites as negative samples. However, certain noisy can be contained in the negative set, as false negative samples are possibly existed. Hence, the performance of the classifiers is not as accurate as they could be due to the biased prediction results. In this work, unknown substrate sites are regarded as unlabeled samples instead of negative ones. We propose a novel positive-unlabeled learning algorithm, namely PU-HIV, for an effective prediction of HIV-1 protease cleavage sites. Features used by PU-HIV are encoded from different perspectives of substrate sequences, including amino acid identities, coevolutionary patterns and chemical properties. By adjusting the weights of errors generated by positive and unlabeled samples, a biased support vector machine classifier can be built to complete the prediction task. In comparison with state-of-the-art prediction models, benchmarking experiments using cross-validation and independent tests demonstrated the superior performance of PU-HIV in terms of AUC, PR-AUC, and F-measure. Thus, with PU-HIV, it is possible to identify previously unknown, but physiologically existed substrate sites that are able to be cleaved by HIV-1 protease, thus providing valuable insights into designing novel HIV-1 protease inhibitors for HIV treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available